Cybin Inc. Common Stock (HELP) Financials

HELP Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 350.3 million 27.0 million
Dec. 31, 2025 289.9 million 16.2 million
Sept. 30, 2025 252.8 million 58.9 million
June 30, 2025 154.7 million 43.3 million

HELP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -37.1 million 3.8 million
Dec. 31, 2025 -32.3 million 4.5 million
Sept. 30, 2025 -48.7 million 525813
June 30, 2025 -21.9 million 552686

HELP Net Income

No data available :(

HELP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 219.3 million - -
Dec. 31, 2025 195.0 million - -
Sept. 30, 2025 116.8 million 40.3 million -
June 30, 2025 87.1 million 32.7 million -

HELP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 36.1 million
Dec. 31, 2025 17.7 million
Sept. 30, 2025 17.4 million
June 30, 2025 16.5 million

HELP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 318414 28.5 million 20.0 million -
Dec. 31, 2025 382687 23.8 million 17.3 million 1.1 million
Sept. 30, 2025 608102 26.3 million 14.0 million 486760
June 30, 2025 169549 15.0 million 9.6 million 752819

HELP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 million 30570
Dec. 31, 2025 - 22356
Sept. 30, 2025 - 28725
June 30, 2025 - 38838

HELP

Price: $7.99

52 week price:
3.76
9.12

Earnings Per Share: -4.25 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 386.8 million

Links: